JP Morgan Downgrades Luminex to Underweight

by Juan Lopez, Benzinga Staff Writer
January 4, 2012 6:50 AM | 6 seconds read |
JP Morgan has downgraded Luminex LMNX from Neutral to Underweight and maintains its $18 price target.
Market News and Data brought to you by Benzinga APIs

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Comments
Posted In: DowngradesPrice TargetPre-Market OutlookAnalyst RatingsHealth CareJP MorganLife Sciences Tools & Services
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!